Source: Annual Congress 2002 - Prevalence and costs of COPD
Disease area: Airway diseases

Abstract

Aim: The study examined the costs of chronic obstructive pulmonary disease (COPD) for the Swedish society, and analysed the costs among those with and without a doctor-diagnosed disease.
Material and methods: During 1999, telephone interviews were made with 212 randomly selected subjects fulfilled criteria for COPD, derived from the Obstructive Lung Disease in Northern Sweden (OLIN) population study. Of these, 72 subjects (34%) had a doctor-diagnosed disease. Classification as mild, moderate, or severe COPD was made according to the BTS guidelines. To reduce recall bias, the subjects were interviewed 4 times (in March, June, September, and December). The costs for the different groups were also transformed with the estimated prevalence in Sweden.
Results: Total costs were SEK 13,418 (EUR 1,448) per patient with COPD. The average total costs were about three times as high for those with a doctor-diagnosed COPD than for those without a doctor-diagnosed disease. With the individual costs measured in this study, the annual total cost to the Swedish society was estimated at SEK 9.1 billion (EUR 982 million). Although the average total costs for subjects without a doctor-diagnosed COPD were lower, the cost accounted for about 50% of the total costs in Sweden, because 66% of the patients did not have a doctor-diagnosed disease.
Conclusions: COPD is a costly disease for the society. We found that subjects without a doctor-diagnosed COPD accounted for approximately a half of the costs for the disease, indicating that register based studies of costs of COPD results in a substantial underestimate.

Rating:

Share or cite this content

Citations should be made in the following way:
S. A. Jansson, A. Ericsson, E. Jönsson, S. Borg, E. Rönmark, F. Andersson, B. Lundbäck (Luleå, Umeå, Lund, Stockholm, Sweden). Costs of chronic obstructive pulmonary disease in Sweden. Eur Respir J 2002; 20: Suppl. 38, 830

Member's Comments

No comment yet.

Related content which might interest you: Epidemiology and costs of chronic obstructive pulmonary disease - Supplementary material: Final Q and A Global Burden of COPD Source: Eur Respir J 2006; 27: 188-207 Year: 2006 Epidemiology and costs of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 27: 188-207 Year: 2006 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 The year in chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical Year in Review Year: 2018 Telemedicine in chronic obstructive pulmonary disease Source: Breathe 2016; 12: 350-356 Year: 2016 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Prevalence of chronic obstructive pulmonary disease (COPD) in Greece Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002 Mortality in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Comorbidities in the course of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Periodontitis and chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 The problems of chronic obstructive pulmonary disease in Kyrgyzstan Source: Eur Respir J 2005; 26: Suppl. 49, 296s Year: 2005 Costs and effectiveness of a disease management program for chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Economic burdens of patients with chronic obstructive pulmonary disease (COPD) in Japan Source: Eur Respir J 2006; 28: Suppl. 50, 108s Year: 2006 Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Socioeconomic burden of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=463 Year: 2006 Diabetes and chronic obstructive pulmonary disease Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Prevalence of chronic obstructive pulmonary disease (COPD) in primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure Year: 2003